Close Menu

UMass

The court found that the university had failed to demonstrate that one of its researchers had collaborated with the IP's inventors and therefore is not entitled to co-inventorship.

The method improves a research tool that can view chromosome movement throughout the living cell nucleus in space and time, and has both research and clinical uses.

Scientists at the University of Massachusetts Medical School will use a three-year, $6.1 million NIH grant to build predictive models of gene expression.

The five new grants, part of the Genomics of Gene Regulation program, will fund research into the mechanisms controlling gene expression.

NEW YORK (GenomeWeb) – An international team led by investigators in the US and China has published a population genomics study that provides new clues about the evolution, behavior, and physical traits that characterize the monarch butterfly, Danaus plexippus.

NEW YORK (GenomeWeb) – A research team spread across four universities has netted a $1.9 million grant from the National Science Foundation to study bats to uncover the genetic, developmental, and anatomical basis of natural selection for their unique sensory structures.

NEW YORK (GenomeWeb) – A US District Court late last month threw out a lawsuit filed by a former University of Massachusetts researcher against the Carnegie Institution of Washington over inventorship of seminal intellectual property related to the discovery of RNA interference.

NEW YORK (GenomeWeb) – In Nature Genetics, an American- and Finnish-led team described the apparent effects of an EGLN1 mutation that's been linked to high-altitude adaptations in the absence o

NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center has provided $8 million in funding to support continued development of the Center for Personalized Cancer Therapy, a joint initiative between the University of Massachusetts Boston and the Dana-Farber/Harvard Cancer Center (DF/HCC

Australian expressed RNAi firm Benitec Biopharma provided an update on its research and development activities late last month, reporting that it remains on track to move its lead drug candidate, the hepatitis C therapy TT-034, into the clinic as early as this month.

Pages

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing inciates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

Bloomberg reports that vaccine developers won't have to conduct large trials of updated vaccines or vaccine boosters aimed at new viral variants.

The SARS-CoV-2 variant uncovered in California may be more transmissible and partially evade vaccine-induced antibody response, the Los Angeles Times reports.